The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
After wildfire smoke blanketed the West, Covid-19 cases and deaths rose
Severe illnesses and deaths from Covid-19 spiked on the West Coast in the weeks after catastrophic wildfires raged across...
-
Can parents help prevent suicides? Experts say there may be no warning signs
By all accounts, Katie Meyer‘s life was moving in a positive direction. Meyer, 22, of Newbury Park, California, was...
-
U.S. to ship 144,000 more monkeypox shots and expand testing as cases top 700
The U.S. is stepping up its efforts to address the snowballing monkeypox outbreak — the country’s largest to date...
-
Study establishes first causal link between anti-trans laws and suicide attempts
State laws targeting transgender people made trans and nonbinary young people more likely to attempt suicide in the past...
-
A new Covid variant has become dominant amid slow uptake of the updated shots
A new Covid variant has become dominant in the U.S., but relatively few people have thus far gotten the...
-
Colts defeat Steelers after losing QB Anthony Richardson to an injury
Indianapolis started Week Four of the NFL season by suffering a notable loss. A few hours later, it earned...
-
Plan your vaccine: Everything you need to know about getting a Covid-19 vaccination
NBC News based its description of the vaccine-eligible population groups on estimates provided by Surgo Ventures, a nonprofit with...
-
Boris Johnson gifts U.K. a Covid-free Christmas — a move experts say could turn fatal
LONDON — British Prime Minister Boris Johnson may have felt giving England a five-day Christmas respite from pandemic restrictions...
Recent Comments